» Articles » PMID: 15111544

Increasing Incidence of Diabetes After Gestational Diabetes: a Long-term Follow-up in a Danish Population

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2004 Apr 28
PMID 15111544
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the incidence of diabetes among women with previous diet-treated gestational diabetes mellitus (GDM) in the light of the general increasing incidence of overweight and diabetes and to identify risk factors for the development of diabetes.

Research Design And Methods: Women with diet-treated GDM during 1978-1985 (old cohort, n = 241, also followed up around 1990) or 1987-1996 (new cohort, n = 512) were examined in 2000-2002. Women were classified by a 2-h, 75-g oral glucose tolerance test according to the World Health Organization criteria or an intravenous glucagon test supplemented by measurement of GAD antibodies. Historical data from index-pregnancy and anthropometrical measurements were collected.

Results: A total of 481 (63.9%) women were examined (median 9.8 years [interquartile range 6.4-17.2]) after index pregnancy. Diabetes and impaired glucose tolerance (IGT)/impaired fasting glucose were present in 40.0 and 27.0% of women, respectively. In the new cohort, 40.9% had diabetes compared with 18.3% in the old cohort at the 1990 follow-up (P < 0.0005). Prepregnancy BMI was significantly higher in the new compared with the old cohort (26.0 [22.5-30.8] vs. 22.9 kg/m2 [20.2-28.0], P < 0.0005). Among others, new-cohort membership, prepregnancy overweight (BMI > or = 25 kg/m2), and IGT postpartum were identified as independent predictors of diabetes by multiple logistic regression analyses.

Conclusions: The incidence of diabetes among Danish women with previous diet-treated GDM was very high and had more than doubled over a 10-year period. This seems to be due to a substantial increase in BMI in women with GDM.

Citing Articles

Effects of diabetes mellitus and cervical changes on scar healing after cesarean section.

Dogru S, Ezveci H, Akkus F, Yaman F, Alp E, Gezginc K J Ultrason. 2024; 24(99):1-7.

PMID: 39720471 PMC: 11665051. DOI: 10.15557/jou.2024.0035.


Identifying microbiome-based changes and biomarkers prior to disease development in mother and child, with a focus on gestational diabetes mellitus: protocol for the DANish Maternal and Offspring Microbiome (DANMOM) cohort study.

Rold L, Jensen A, Arenholt L, Leutscher P, Ovesen P, Hagstrom S BMJ Open. 2024; 14(9):e083358.

PMID: 39242166 PMC: 11381651. DOI: 10.1136/bmjopen-2023-083358.


Characterization of genetic variants of GIPR reveals a contribution of β-arrestin to metabolic phenotypes.

Kizilkaya H, Sorensen K, Madsen J, Lindquist P, Douros J, Bork-Jensen J Nat Metab. 2024; 6(7):1268-1281.

PMID: 38871982 PMC: 11272584. DOI: 10.1038/s42255-024-01061-4.


A comparison of the breast milk microbiota from women diagnosed with gestational diabetes mellitus and women without gestational diabetes mellitus.

Rold L, Guldbaek J, Lindegaard C, Kirk S, Nygaard L, Bundgaard-Nielsen C BMC Pregnancy Childbirth. 2024; 24(1):412.

PMID: 38849751 PMC: 11157733. DOI: 10.1186/s12884-024-06604-x.


The Placental Role in Gestational Diabetes Mellitus: A Molecular Perspective.

Calvo M, Parra H, Santeliz R, Bautista J, Luzardo E, Villasmil N touchREV Endocrinol. 2024; 20(1):10-18.

PMID: 38812661 PMC: 11132656. DOI: 10.17925/EE.2024.20.1.5.